Journal For Clinical Studies

Current Edition

Current Features

Current features

Ensuring Flexibility when Approaching CTIS

When Catalyst Oncology implements the European Union Clinical Trial Regulation (EU CTR) across Sponsor studies the Site Activation Management (SAM) team is often ask...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Pulse Oximeters and Addressing the Potential for Bias

As a result of the coronavirus disease 2019 (COVID-19) public health emergency, pulse oximeter usage has increased in both hospital and home settings. The US Food an...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Rethinking Big Data Will Lead to New Advances in Personalised Medicine

The life sciences industry has waited a long time for big data to transform the potential of personalised medicine. With AI and machine learning now coming of age, R...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Changing the Narrative of First in Human Oral Drug Development: The SMART Advantage

In the intricate realm of pharmaceutical development, First Human Dose (FHD) studies represent a pivotal juncture, replete with complexities yet essential for advanc...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Reviewing Research Participant Payments Through a Diversity Lens

Whether and how a participant is compensated for taking part in a clinical study are two of the decisions an institutional review board (IRB) makes when approving re...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Designing and Executing a Robust Feasibility in Rare Disease Clinical trials

Rare disease studies, especially those conducted in paediatric populations, present considerable challenges at a country, site and patient level due to their complex...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current Edition

Current features

Ensuring Flexibility when Approaching CTIS

When Catalyst Oncology implements the European Union Clinical Trial Regulation (EU CTR) across Sponsor studies the Site Activation Management (SAM) team is often ask...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Pulse Oximeters and Addressing the Potential for Bias

As a result of the coronavirus disease 2019 (COVID-19) public health emergency, pulse oximeter usage has increased in both hospital and home settings. The US Food an...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Rethinking Big Data Will Lead to New Advances in Personalised Medicine

The life sciences industry has waited a long time for big data to transform the potential of personalised medicine. With AI and machine learning now coming of age, R...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Changing the Narrative of First in Human Oral Drug Development: The SMART Advantage

In the intricate realm of pharmaceutical development, First Human Dose (FHD) studies represent a pivotal juncture, replete with complexities yet essential for advanc...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Reviewing Research Participant Payments Through a Diversity Lens

Whether and how a participant is compensated for taking part in a clinical study are two of the decisions an institutional review board (IRB) makes when approving re...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Current features

Designing and Executing a Robust Feasibility in Rare Disease Clinical trials

Rare disease studies, especially those conducted in paediatric populations, present considerable challenges at a country, site and patient level due to their complex...

29 July 2024 Current features | Volume 16 Issue 2

Continue Reading →

Company Profiles

Company Profile

Emmes

The Industry’s First Native Digital and AI Specialty CRO Advancing human health with scientific rigor and integrity Welcome to Emmes, a full-service clinical r...

17 April 2024 Company Profile | E-M

Continue Reading →